The world's scientific and social network for malaria professionals
8754 malaria professionals are enjoying the free benefits of MalariaWorld today


News from MESA: The Armed Forces Pest Management Board (AFPMB) joins the MESA Track database

October 8, 2015 - 17:13 -- MESA Alliance
The Armed Forces Pest Management Board (AFPMB) of the United States Department of Defense, in collaboration with MESA, has included its research portfolio on the MESA Track database. Click here to access the AFPMB portfolio.

The ambiguous role of glutathione in malaria

October 3, 2015 - 19:41 -- Pierre Lutgen

Parasites are endowed with powerful and host-independant mechanisms which de novo synthesize or regenerate reduced glutathione (GSH) and protect the parasites from oxidative damage. GSH can penetrate from the extracellular space into the host cytosol but the parasite membrane is impermeable to peptides (H Atamna et al., Eur J Biochem 1997, 15, 670-9).. Glutathione is one of the most powerful anti-oxidants. It is a tripeptide formed by the amino acids glycine, cysteine and glutamic acid. It inhibits the action of arginine which produces NO and expels it from the food vacuole.

Last week at MalariaWorld: from aspiration to action, and a job opportunity at Sanaria

October 2, 2015 - 09:25 -- Ingeborg van Schayk

Bill Gates, Co-chair of the Bill & Melinda Gates Foundation, and Ray Chambers, the UN Secretary-General's Special Envoy for Financing the Health Millennium Development Goals and for Malaria, released an in-depth report on what it will take to eradicate malaria on 28 September. It declares that eradication can be achieved by 2040 if world leaders commit to making it a reality, and they call on leaders to launch a global debate on the issue.From Aspiration to Action is dedicated to the memory of the late Alan Magill, who served as Director of the Gates Foundation Malaria Program. This document reflects his vision for a malaria-free world. Read the full report "From Aspiration to action: what will it take to end malaria" here.

Then there is a new job opportunity at Sanaria Inc. for a Physician Investigator to be located in Eduqatorial Guinea. U.S. citizenship or permanent resident status is required. Read the vacancy announcement "Physician Investigator Malaria Vaccine" here.

Enjoy this week's MalariaWorld - the MW team

and we look forward to receiving your manuscripts!


MalariaWorld has been nominated for a Social Media Award 2015! It will be greatly appreciated if you endorse us. Read more about the awards here.



Support MalariaWorld to provide Open Access to malaria information for all.  We will use your donation solely to further develop MalariaWorld. MalariaWorld is a project of the Dutch Malaria Foundation, a charitable, registered, not-for-profit organisation. If you still have any questions then just contact us at


MalariaWorld Journal (MWJ) is the only peer-reviewed Open Access journal on malaria where you don’t pay to publish, you don’t pay to read, and authors get paid € 150 for each published paper. Read about MW and how you can submit your manuscript here.


Log in at MalariaWorld. Remember that you have to log-in at MW to read more, respond to polls, open attachments and get free copies of books and other documents. Forgot your username and/or password? Go to, click on Sign in and then on Request new password. Fill out your email address that you use to receive the MW newsletter and the Word verification. You will then receive further instructions by email.


In Memoriam: Dr. Alan Magill

September 25, 2015 - 08:38 -- Bart G.J. Knols

It is with profound sadness that we took notice today of the untimely death of Dr. Alan Magill, who headed the malaria programme at the Gates Foundation in Seattle. Below we copy the press release from the Gates Foundation.

I met Alan for the first time in Durban, South Africa, during the MIM meeting in 2013. This was not long after he had taken up his new position at the Gates Foundation. This was the man that everyone out of the 1500+ participants would like to talk to, and it was a great privilege that he took some time to sit down and chat with me. It struck me immediately how pleasant Alan was to interact with. Down-to-earth, direct, and above all with passion did he speak of his mission to free the world of malaria. And I vivdly remember his following words: 'Being with the Foundation now gives me the real opportunity to make a difference in this world'.

The second time we met was when I visited the Foundation in January this year. As ever, Alan was pleasant and at the same time razor sharp. He needed two words to understand your full story. Over lunch his passion got hold of him when he stood up and expressed his frustration that we were all going too slow - that we needed to get new technology to the field quicker. Every live mattered, and waiting would only lead to unnecessary waste of lives. So true.

The world has lost a great malariologist. It is now upon us to follow in his footsteps and end malaria.

The MESA Alliance shares heartfelt condolences for the loss of Alan Magill

September 25, 2015 - 07:53 -- MESA Alliance

Dear Friends and Colleagues,

On behalf of the MESA Alliance, we wanted to share our heartfelt condolences for the loss of Alan Magill.

Alan held a deep-rooted belief that humankind should and could defeat malaria. He made an extraordinary commitment towards realising this goal.

Report: Landscape of new vector control products

September 23, 2015 - 19:37 -- Bart G.J. Knols

VectorWorks is pleased to announce the release of a new report, Landscape of New Vector Control Products written by Michael MacDonald. The report covers the spectrum of new vector control products, highlighting descriptions of how each of the tools work; general timelines for their implementation; and limitations of each approach. While these tools are unlikely to be as widely scalable as IRS and ITNs, they are promising components of an Integrated Vector Management strategy.

The report is attached below. 

E-interview with Dr. Silas Majambere (Burundi, 1975)

September 23, 2015 - 12:59 -- Bart G.J. Knols
Dr. Silas Majambere is a medical entomologist who took up the position od senior scientist with the Innovative Vector Control Consortium recently. MalariaWorld asked Silas about his past work and future ambitions in the field of malaria elimination.
You have been working directly in the field of operational malaria control in The Gambia using larval control. What is your current opinion on the role of larval control? Is it indeed a matter of ‘few, fixed, and findable’ sites or is there a wider role for larval control?
I have spent four years in The Gambia investigating the role of larviciding for malaria control. The program covered 400 km2 of floodplains with ground teams of spraymen applying Bacillus thuringiensis Israelensis (Bti) weekly to all water bodies we had previously mapped. This was indeed hard work at +40 degrees Celsius, and I commend the team that took the task. Unfortunately we only had a small impact on adult mosquito density and were not able to show a reduction in malaria prevalence following the larviciding program.
There were two main reasons we were not able to show impact: (1) the extent of the floodplains is simply too large to spray by ground teams, unless bigger teams are deployed; (2) Gambia river is highly tidal and Bti is likely to have been washed away after application.
Larval source management (LSM) has a role in malaria control, and it is not just my opinion, but it is historically proven (Brazil, Israel, USA, etc.). Although I understand the caution around “few, fixed and findable”, those terms are very relative and should not distract us.
Many African countries have adopted LSM for malaria control, and it is one of the tools in their Strategic Plans. While the scientific community is debating, the train has moved, and we’d better catch up and support the countries adopt best practices for LSM, including robust monitoring and evaluation, and use of WHOPES recommended products. With the technology we have today, I believe we can design better LSM programs than 80 years ago in Brazil.

Eradication or suppresion?

September 21, 2015 - 11:36 -- William Jobin

What are the benefits of eradicating malaria, compared to suppressing it?

Eradication is a distant goal, perhaps one not attainable in our lifetime – perhaps never. Even its definition is somewhat vague, as there are so many forms of malaria. However suppression of malaria transmission is real and immediately attainable, something we are actually doing right now, in various degrees.

Why can't WHO give out accurate data about bednets ?

September 19, 2015 - 20:14 -- William Jobin

This month’s report by WHO/UNICEF on ‘Achieving the Malaria MDG Target’ indicated that over 50% of Congolese children sleep under bednets. However these overly optimistic assertions are contradicted by a careful malaria survey conducted in 2007 in 8,000 households in the Congo, which indicated a blood-slide positivity of 33.5% and only 7% of children sleeping under bednets (Molecular malaria epidemiology…… by Taylor et al DOI: 10.1371/journal.pone.0016420.

Santonin from Artemisia campestris: a famous forgotten anthelmintic.

September 18, 2015 - 06:04 -- Pierre Lutgen

200 years ago, in 1830 the anthelmintic properties of santonin were discovered , simultaneously by Dr Kahler in Düsseldorf and Dr Alms in Mecklenburg in a plant from Turkestan, Artemisia cina. Its presence, although at lower concentrations, was later found in Artemisia maritima, Artemisia campesris, Artemisia gallica, Artemisia absinthium, Artemisia sieberi. (Berichte der Deutschen Chemischen Gesellschaft , 1867, Vol 6, 875-1670). Stanislao Cannizzaro is known widely for his , "Sunto di un corso di filosofia chimica", on santonin which he presented at the Karlsruhe Congress of 1860.

Dams can be operated in ways to prevent disease, especially malaria

September 11, 2015 - 16:18 -- William Jobin

I fully support the conclusions of Solomon Kibret and colleagues about the health impact of dams in the tropics, especially regarding diseases transmitted by mosquitoes and aquatic snails.
REF just published in Malaria Journal - Malar J. 2015; 14: 339. Published online 2015 Sep 4. doi: 10.1186/s12936-015-0873-2 PMCID: PMC4560078
The title is : Malaria impact of large dams in sub-Saharan Africa: maps, estimates and predictions
by Solomon Kibret,corresponding author and Jonathan Lautze, Matthew McCartney, G. Glenn Wilson, and Luxon Nhamo.

Cod liver oil: a stronger prophylactic against malaria than vaccines!

September 8, 2015 - 14:24 -- Pierre Lutgen

In 1957 the University of London found that dietary cod liver oil suppressed the multiplication of Plasmodium berghei in mice (DG Godfrey, Experimental Parasitology, 1957, 6, 555-565), of Babesia rodhaini (DG Godfrey, Experimental Parasitology 1957, 6-5, 465-485) and of Trypanosoma congolense (D G Godfrey , Experimental Parasitology, 1958, 3, 255-268).

The making of a PNAS's our story

September 3, 2015 - 20:35 -- Bart G.J. Knols

Once a scientific paper is published online and you can download a pdf of it, this addictive and magnificent feeling gets on to you. This is the fruit of all the hard work: first to get the funding to undertake the research, then the hard work to actually perform all the research, then the hard work to write up the manuscript, then the submission, the reviews, the rebuttal, and eventually acceptance followed by proof reading and then publication. The route from thinking up research to publishing about it is long, tedious, and really hard work. But why don't we ever talk about this route? Why do we publish our papers but don't tell our peers more about how we got there? The fun parts, the sweat and tears, or even the fights? This week we published an article in the Proceedings of the National Academy of Sciences USA (PNAS; attached below). And here's the story you don't know when you read the paper...

African Institute for Ecological Suppression of Malaria

August 31, 2015 - 13:42 -- William Jobin

I invite you to help me imagine a solid and realistic approach to malaria control in Africa, rather than continuing our criticism of the current poorly focussed and unsustainable attempts by WHO, RBM and the US PMI. I think we need a permanent Institute where African malaria people can develop, implement and expand anti-malarial measures. Because the current emphasis on drugs, biocides and bednets is inherently unsustainable, let us take a more sensible and rational approach which utilizes ecological changes.

Artemisia annua efficiently cures bilharzia

August 26, 2015 - 19:36 -- Pierre Lutgen

Bilharzia, schistosomiasis, snail fever, is a disease caused by parasitic worms of the Schistosoma type. It may infect the urinary tract or the intestines. Signs and symptoms may include abdominal pain, diarrhea, bloody stool, or blood in the urine. In those who have been infected for a long time, liver damage, kidney failure, infertility, or bladder cancer may occur. Schistosomiasis affects almost 210 million people worldwide, and an estimated 200,000 people die from it a year, 

Artemisia annua from Luxembourg efficiently kills gametocytes!

August 20, 2015 - 18:56 -- Pierre Lutgen

A team of medical doctors and traditional healers in the Eastern part of the DR Congo just completed the first part of clinical trials studying the efficacy of Artemisia annua against gametocytes. The trials were following a protocol based on the procedures recommended by WHO and are coordinated with a team of medical doctors from France.

Bicarbonates, hydrogen peroxide and malaria.

August 13, 2015 - 15:28 -- Pierre Lutgen

Polyphenols are a large group of antioxidants naturally known for their protective effect against oxygen metabolites, acting as free radical scavengers. In contrast to the beneficial effects it has recently been reported that some polyphenols may promote oxidative damage. These harmful effects are suspected to result from a pro-oxidant action.

Proline: fuel for parasites, worms, bacteria, fungi.

July 31, 2015 - 18:06 -- Pierre Lutgen

After some important research work had been done some 30 years ago on amino acids, the impact these molecules might have on a vast array of diseases has been neglected. But there is increasing evidence that the amino acid proline plays an important role in the virulence mechanism of human and mammalian pathogens.

Testing for malaria reduces overprescription by over 70%

July 24, 2015 - 08:19 -- Ingeborg van Schayk

Introducing rapid diagnostic tests in Ugandan drug shops improves treatment of malaria patients

Using malaria rapid diagnostic tests (RDT) in registered drug shops in a highly endemic region in Uganda substantially reduced overdiagnosis of malaria, improving the use of valuable malaria drugs, according to a new study published in PLOS ONE.

Artemisia: efficient but banished (FRENCH VERSION)

July 22, 2015 - 16:43 -- Pierre Lutgen

As most of the people suffering from malaria are living in French speaking countries we post also a French version


Les plantes de la grande famille des armoises sont utilisées comme herbes médicinales depuis des millénaires dans toutes les régions du monde.

L’Artemisia annua est venue sous les feux de la rampe lors de la guerre du Vietnam.

President's Malaria Initiative (PMI): Country insecticide susceptibility summaries

July 17, 2015 - 08:25 -- Bart G.J. Knols
This contribution was provided by Dr. Christen Fornadel, Senior Malaria Vector Control Specialist at PMI.
The President’s Malaria Initiative (PMI) has made increasing investments in entomological monitoring across all 19 program countries in order to monitor the effects of two of PMI’s four main interventions, distribution of long-lasting, insecticide treated bed nets (LLINs) and indoor residual spraying (IRS), both of which are aimed at controlling mosquito populations. Both of these interventions are insecticide based, so as they are scaled up, one can expect to see changes in the species composition of the vector population and possibly changes in malaria mosquito behavior. But most importantly, we have already seen and are likely to continue to see changes in mosquito susceptibility to the insecticides used on LLINs and for IRS. As malaria vector control has escalated across Africa, so have the number of reports of pyrethroid resistance in both major vector groups, Anopheles gambiae s.l. and An funestus s.l., and today it is rare to find sites in Africa where one or both these vectors do not show some level of pyrethroid resistance. The global community spends hundreds of millions of dollars on malaria control, so it is important to make sure that we are doing entomological monitoring to see that our investments are making an impact, and that those resources are not wasted.

New from MESA: Refreshing the Malaria Eradication Research Agenda

July 9, 2015 - 19:01 -- MESA Alliance

More than four years after the publication of the Malaria Eradication Research Agenda (malERA), which identified knowledge gaps and tools that will be needed to eradicate malaria, the Malaria Eradication Scientific Alliance (MESA) is leading a consultative process to assess the progress made, examine current hypotheses and identify priority research areas in the next 5-10 years.

Arginine, a deadly weapon against gametocytes.

July 5, 2015 - 20:26 -- Pierre Lutgen

Amino-acids in Artemisia annua have barely been studied. The analytical data published by EA Brisibe and J Ferreira date back to 2009 (Food Chemistry, 2009, 115, 1240-1246). Their role in malaria infections has been ignored, except for a study published in Japan (DT Uyen et al., Biol Pharm Bull. 2008, 31, 1483-1488). To gain insight into the mechanism of malarial haemozoin formation, they examined the effects of amino acids on beta hematin formation in vitro. Surprisingly some of these amino acids like arginine, histidine, lysine showed a significant inhibition.

The International PfSPZ Consortium meets to review data and map out the clinical development pathway for the Plasmodium falciparum sporozoite-based vaccines

July 2, 2015 - 17:38 -- Ingeborg van Schayk

Candidate vaccines based on injectable Plasmodium falciparum (Pf) sporozoites (SPZ), are being developed and tested. These include PfSPZ Vaccine, in which the PfSPZ are attenuated by irradiation; PfSPZ-CVac, in which fully infectious PfSPZ, PfSPZ Challenge, are attenuated in vivo by an anti-malarial drug, to allow only liver stage parasites to grow, and PfSPZ-GA1, in which the PfSPZ are attenuated by gene deletions.


Subscribe to Weblogs